Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeo Kosaka

Showing results (11-20 of 326) with videos related to

Pageof 33
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 2, 2015
Complete response to ethnylestradiol prolonged for almost two years in patients with castration-resistant prostate cancerHiroshi Hongo, Takeo Kosaka, Mototsugu Oya
Molecular and Clinical Oncology|December 15, 2018
Risk stratification of castration-resistant prostate cancer patients treated with cabazitaxelTakeo Kosaka, Hiroshi Hongo, Ryuichi Mizuno, et al.
Reviews on Recent Clinical Trials|May 26, 2009
Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital CancerAkira Miyajima, Eiji Kikuchi, Takeo Kosaka, et al.
IJU Case Reports|August 4, 2020
Clinically complete response to abiraterone acetate in a patient with metastatic castration-resistant prostate cancerYoshinori Yanai, Takeo Kosaka, Hiroshi Hongo, et al.
Scientific Reports|April 17, 2021
Utility of prophylactic antibiotics for preventing febrile neutropenia during cabazitaxel therapy for castration-resistant prostate cancerKeitaro Watanabe, Takeo Kosaka, Hiroshi Hongo, et al.
International Cancer Conference Journal|July 5, 2021
A long-term survivor of metastatic neuroendocrine prostate cancer treated with multimodal therapy: genetic consideration from next-generation sequencingHiroshi Hongo, Takeo Kosaka, Seishi Nakatsuka, et al.
Clinical and Experimental Nephrology|January 23, 2008
Metastatic type-2 papillary renal cell carcinoma responded to interleukin-2 therapy: case reportTakeo Kosaka, Shuji Mikami, Akira Miyajima, et al.
BMJ Case Reports|August 30, 2014
Ureteral metastasis from prostate cancerHiroshi Hongo, Takeo Kosaka, Shunsuke Yoshimine, et al.
BMC Cancer|July 24, 2019
Interstitial pneumonitis in a castration-resistant prostate cancer patient receiving cabazitaxel after thoracic radiation therapy: a case reportYoshinori Yanai, Takeo Kosaka, Hiroshi Hongo, et al.
Journal of Human Genetics|April 23, 2023
Clinical risk management of breast, ovarian, pancreatic, and prostatic cancers for BRCA1/2 variant carriers in JapanArisa Ueki, Reiko Yoshida, Takeo Kosaka, et al.
Pageof 33

Showing results (11-20 of 326) with videos related to

Sort By:
Pageof 33
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 2, 2015
Complete response to ethnylestradiol prolonged for almost two years in patients with castration-resistant prostate cancerHiroshi Hongo, Takeo Kosaka, Mototsugu Oya
Molecular and Clinical Oncology|December 15, 2018
Risk stratification of castration-resistant prostate cancer patients treated with cabazitaxelTakeo Kosaka, Hiroshi Hongo, Ryuichi Mizuno, et al.
Reviews on Recent Clinical Trials|May 26, 2009
Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital CancerAkira Miyajima, Eiji Kikuchi, Takeo Kosaka, et al.
IJU Case Reports|August 4, 2020
Clinically complete response to abiraterone acetate in a patient with metastatic castration-resistant prostate cancerYoshinori Yanai, Takeo Kosaka, Hiroshi Hongo, et al.
Scientific Reports|April 17, 2021
Utility of prophylactic antibiotics for preventing febrile neutropenia during cabazitaxel therapy for castration-resistant prostate cancerKeitaro Watanabe, Takeo Kosaka, Hiroshi Hongo, et al.
International Cancer Conference Journal|July 5, 2021
A long-term survivor of metastatic neuroendocrine prostate cancer treated with multimodal therapy: genetic consideration from next-generation sequencingHiroshi Hongo, Takeo Kosaka, Seishi Nakatsuka, et al.
Clinical and Experimental Nephrology|January 23, 2008
Metastatic type-2 papillary renal cell carcinoma responded to interleukin-2 therapy: case reportTakeo Kosaka, Shuji Mikami, Akira Miyajima, et al.
BMJ Case Reports|August 30, 2014
Ureteral metastasis from prostate cancerHiroshi Hongo, Takeo Kosaka, Shunsuke Yoshimine, et al.
BMC Cancer|July 24, 2019
Interstitial pneumonitis in a castration-resistant prostate cancer patient receiving cabazitaxel after thoracic radiation therapy: a case reportYoshinori Yanai, Takeo Kosaka, Hiroshi Hongo, et al.
Journal of Human Genetics|April 23, 2023
Clinical risk management of breast, ovarian, pancreatic, and prostatic cancers for BRCA1/2 variant carriers in JapanArisa Ueki, Reiko Yoshida, Takeo Kosaka, et al.
Pageof 33